Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin’s Lymphoma

Overview of attention for article published in PharmacoEconomics, September 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 53 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Non-Hodgkin’s lymphoma: diagnosis and management : Appendices A-F

Cited by National Institute for Health and Care Excellence on 13 Jul 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Non-Hodgkin’s lymphoma: diagnosis and management : Full guideline

Cited by National Institute for Health and Care Excellence on 13 Jul 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.